Another drug warning for current/future expectant moms
If you have migraine headaches or epilepsy AND you are or plan to get pregnant, take note of this drug warning:
The Food and Drug Administration today said new data suggests women who take Topamax (topirimate) or generic versions of this medication during their pregnancy have an increased risk of the birth defects cleft lip and cleft palate in their babies.
Topamax is prescribed both to control seizures in people with epilepsy and to prevent migraine headaches.
Data from the North American Antiepileptic Drug Pregnancy Registry showed an increased risk of oral clefts (cleft lip and cleft palate collectively) in infants of mothers who took topiramate during their first trimester of pregnancy, according to the FDA.
Based on data, the FDA says, topiramate will carry a stronger warning label pertaining to pregnancy information. Doctors are being advised to weigh the benefits and risks when prescribing this medication to women of child-bearing age.